Aetion

Healthcare professional looking at data on a screen
Datavant acquires Aetion to expand RWE platform
By Anthony Vecchione | 01:43 pm | May 16, 2025
The combination will allow healthcare and life sciences companies to respond more efficiently to research questions.  
Two people sitting with one embracing the other
Aetion, FDA partner on oncology real-world data
By Jessica Hagen | 05:08 pm | January 24, 2023
The FDA's Oncology Center of Excellence will use Aetion's Evidence Platform to find and analyze sources of real-world data that could be used for research.
Clinicians looking at screen
Aetion snaps up Replica Analytics
By Laura Lovett | 11:48 am | January 04, 2022
The acquisition comes less than a year after Aetion landed $110 million in Series C funding. 
Group looking at data
Real-world evidence startup Aetion lands $110M in Series C as it looks toward global expansion
By Laura Lovett | 03:32 pm | May 11, 2021
The company has now raised a total of $212 million. 
Real-world evidence platform Aetion adds $19M to last year's Series B raise
By Dave Muoio | 12:35 pm | August 26, 2020
A frequent partner of biopharmas and the FDA, it has raised $94 million from investors since its commercial launch in 2015. 
Aetion, HealthVerity collaborate on real-world data for COVID-19 treatments, Aptar Pharma, Sonmol co-developing digital respiratory offerings and more digital health deals
By Dave Muoio | 03:54 pm | April 22, 2020
Also: HomeStay to distribute, integrate G Medical's remote monitoring tech; Imprivata and Microsoft announce new health IT security offerings.
Glooko's newest executives, Aetion's cross-industry data expert and more digital health hires
By Dave Muoio | 04:50 pm | February 17, 2020
Also: Jonathan Bush, Dr. Scott Gottlieb embrace the board of directors.
Aetion's real-world data analytics platform raises $27M, caps off $63M Series B round
By Dave Muoio | 12:23 pm | February 05, 2019
The new funding will primarily serve to expand the Aetion Evidence Platform.